148 related articles for article (PubMed ID: 6352224)
1. Reductive drug metabolism.
Mc Lane KE; Fisher J; Ramakrishnan K
Drug Metab Rev; 1983; 14(4):741-99. PubMed ID: 6352224
[No Abstract] [Full Text] [Related]
2. Toxicological implications of drug metabolism.
Welch RM
Pharmacol Rev; 1978 Dec; 30(4):457-67. PubMed ID: 392540
[No Abstract] [Full Text] [Related]
3. Relationship between NADH and NADPH oxidation during drug metabolism.
Sasame HA; Mitchell JR; Thorgeirsson S; Gillette JR
Drug Metab Dispos; 1973; 1(1):150-5. PubMed ID: 4129866
[No Abstract] [Full Text] [Related]
4. [Hepatic metabolism of foreign substances. Enzymatic hydroxylation system of hepatic microsomes and of cytochrome P-450].
Valla D
Med Chir Dig; 1978; 7(3):259-62, 265-6. PubMed ID: 28455
[No Abstract] [Full Text] [Related]
5. Drug metabolism: prospects for the future.
Leibman KC
Drug Metab Rev; 1979; 10(2):299-309. PubMed ID: 121804
[No Abstract] [Full Text] [Related]
6. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
[No Abstract] [Full Text] [Related]
7. Studies on the molecular function of cytochrome P-450 during drug metabolism.
Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
[No Abstract] [Full Text] [Related]
8. Renal drug metabolism.
Lohr JW; Willsky GR; Acara MA
Pharmacol Rev; 1998 Mar; 50(1):107-41. PubMed ID: 9549760
[No Abstract] [Full Text] [Related]
9. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
Correia MA; Mannering GJ
Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
[No Abstract] [Full Text] [Related]
10. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
Wada O; Yano Y
Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
[No Abstract] [Full Text] [Related]
11. Cytochrome P450/NADPH-dependent formation of trans epoxides from trans-arachidonic acids.
Roy U; Loreau O; Balazy M
Bioorg Med Chem Lett; 2004 Feb; 14(4):1019-22. PubMed ID: 15013014
[TBL] [Abstract][Full Text] [Related]
12. [Action of substances altering the intracellular cAMP level on the enzymes of the oxidative metabolism of xenobiotics].
Bushma MI; Lukienko PI; Legon'kova LF
Farmakol Toksikol; 1986; 49(2):49-52. PubMed ID: 3011493
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and drug metabolism.
Jones DP
Biochem Pharmacol; 1981 May; 30(10):1019-23. PubMed ID: 7259789
[No Abstract] [Full Text] [Related]
14. Commentary: drug metabolism and pharmacogenetics.
La Du BN
Drug Metab Dispos; 1983; 11(4):283-5. PubMed ID: 6137331
[No Abstract] [Full Text] [Related]
15. Hepatic cytochrome P-450.
Paine AJ
Essays Biochem; 1981; 17():85-126. PubMed ID: 6795037
[No Abstract] [Full Text] [Related]
16. Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.
Cohen GM; Mannering GJ
Drug Metab Dispos; 1974; 2(3):285-92. PubMed ID: 4153061
[No Abstract] [Full Text] [Related]
17. Oxidation and conjugation of aflatoxins by humans and experimental animals.
Guengerich FP; Raney KD; Kim DH; Shimada T; Meyer DJ; Ketterer B; Harris TM
Prog Clin Biol Res; 1992; 374():157-65. PubMed ID: 1620701
[No Abstract] [Full Text] [Related]
18. Perinatal development of tertiary amine N-oxidation and NADPH cytochrome C reduction in rat liver microsomes.
Uehleke H; Reiner O; Hellmer KH
Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):793-805. PubMed ID: 4405002
[No Abstract] [Full Text] [Related]
19. Identification of an NADP/thioredoxin system in Chlamydomonas reinhardtii.
Huppe HC; Picaud A; Buchanan BB; Miginiac-Maslow M
Planta; 1991; 186():115-21. PubMed ID: 11538123
[TBL] [Abstract][Full Text] [Related]
20. [Fundamentals of drug metabolism].
Netter KJ
Arzneimittelforschung; 1972 Feb; 22(2):285-92. PubMed ID: 4402072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
